Claudia Leemereise

Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD

Anthony Cahn, J. Hamblin, Malcolm Begg et al. · Pulmonary Pharmacology & Therapeutics · 2017 · 68 citations · Full text

A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma

Sanjeev Khindri, Anthony Cahn, Malcolm Begg et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 36 citations · Full text

Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the <i>vastus lateralis</i> (lateral thigh) muscles of healthy adult participants

Kelong Han, Hakop Gevorkyan, Jafar Sadik Shaik et al. · Antimicrobial Agents and Chemotherapy · 2023 · 19 citations · Full text

An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial

Anthony Cahn, J. Hamblin, Jon Robertson et al. · International Journal of COPD · 2021 · 17 citations · Full text

Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy Individuals

Robert Wilson, A.G.B. Templeton, Claudia Leemereise et al. · Clinical Therapeutics · 2019 · 12 citations

Drug Safety, Asthma, Pharmaceutical Science +7